Length of treatment. Three questions for prescribers
BMJ
.
2010 Sep 15:341:c5013.
doi: 10.1136/bmj.c5013.
Authors
Jeffrey K Aronson
,
Robin E Ferner
PMID:
20843922
DOI:
10.1136/bmj.c5013
No abstract available
Publication types
Comment
Letter
MeSH terms
Evidence-Based Medicine
Humans
Prescription Drugs* / administration & dosage
Prescription Drugs* / adverse effects
Risk Assessment
Time Factors
Substances
Prescription Drugs